S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Why Purpose-Driven Marketplaces Are the Antidote to Amazon

Saturday, October 23, 2021 | Entrepreneur


As the child of a nomadic entrepreneur, I moved around a lot. I’ve been to 45 of the 50 U.S. states and lived in eight. It wasn’t until my early 30s, however, that I made my way to Oregon and the “maker city” of Portland. The culture was like nothing I’d experienced. Walking down the neighborhood streets, free of chain stores, it dawned on me how rare it was to be in a community where local, small businesses thrive. 

In the early days of the crisis, the world digitized. We learned, worked, exercised and shopped online. In what many thought would be a temporary shift, the visibility and convenience factor of ecommerce giants like Amazon has endangered our small business economy. A survey by the Institute for Local Self-Reliance reveals three-quarters of independent retailers see Amazon’s dominance as a major threat to their survival. It is. 

From 2007 to 2017, while Amazon secured its ascent, the number of small retailers fell by 65,000. About 40 percent of the nation’s small apparel, toy and sporting goods makers disappeared, along with about one-third of small book publishers. 

It doesn't have to be this way. Values-based marketplaces are emerging to promote local, small businesses on a global scale. These online hubs enable consumers to find products based on what matters to them most. They are the digital equivalent to knowing the maker down the street, and they might just be the antidote to Amazon’s war on small business — that is, if consumers buy in.

Related: The Future of Online Shopping Is 'Buy Now, Pay Later'

Behind the curtain of Amazon’s "benevolent monopoly"

In Dave Eggers’ new satire The Every he paints a dystopian future where a fictional search engine company buys an ecommerce giant. The corporate juggernaut algorithmically controls access to everything from housing to food to jobs, however, its abuse of power is disguised under what Eggers calls “benevolent market mastery.” 

In the non-fiction world, the real Amazon invests a lot in PR efforts to portray itself as a community player that has “a mutually beneficial relationship” with small businesses. Yet only 11 percent of companies selling on its site describe their experience as successful.

From cornering the online market and blocking small businesses from having relationships with their customers to selling goods below cost to dominate market share, Amazon’s benevolent optics are stained with unscrupulous practices. 

I’m not suggesting ecommerce giants such as Amazon don't have a place in the retail market. If a customer lives far away from a major city and can’t buy bandaids or key medical supplies, they should be able to get their commodities online. However, when these massive global corporations promote a destructive cycle of production, consumption and convenience at all costs, we have to stop and ask ourselves: What will our retail world look like 10 years from now?

Related: 5 Online Shopping Trends to Watch This Holiday Season

Convenience is killing our retail biodiversity

Last year, as I was setting up my Portland home, I needed a dresser and conveniently purchased it on Wayfair. The next day as I was driving around my new neighborhood, I realized there was a local furniture store five minutes away with great stock. It wasn’t from a lack of desire that I hadn't stopped there before, it was a lack of awareness. 

The lack of awareness for small businesses through online search is an internet-wide problem. Ads and SEO-savvy corporations dominate both paid and organic search creating an unlevel playing field for local shops. Only two percent of brands own the first page of search results on Google and it’s only getting worse. 

Values-based marketplaces can change this. As consumers become more aware of where to go shopping based on their values, they can consciously choose to bypass tech giants such as Amazon. This is how we can build a more sustainable and diverse small business economy. 

When you buy from a small business in your neighborhood, that money circulates back into the local economy supporting local job growth and paying for community infrastructures such as public schools and hospitals. When you buy from Amazon, 30 percent of your money goes back to Amazon. Think about that. Was it your intention to fund Bezos’s space race? 

Thankfully, more people are realizing the power of their buying habits and use them to shape the future they want to see. In 2020, Gen Z and Millenials spent $3 trillion shopping from businesses that reflected their values. 82 percent said they’d spend more to support local businesses post-pandemic. 

Eggers’s dystopian vision of an America ruled by corporate dictatorship is a cautionary tale of what can happen if we don’t realize the real cost of our spending decisions. I’d argue that we’re standing on the edge of that cliff. 

Still, I am optimistic in our ability to make different, better choices. In the past year, we’ve seen people come together to change laws systematically designed to suppress entire populations. I believe we can all learn to shop our values. It’s time we embrace our power as consumers, one click at a time.

Related: 14 Tips for Safe Online Shopping


7 Pharmaceutical Stocks to Buy For a Healthy Portfolio in 2022

One year ago, investors expected 2021 to be a huge year for pharmaceutical stocks. The bullish perspective was that as vaccines rolled out and the economy reopened, investors would shift from biotech stocks to traditional pharmaceutical stocks.

But the Delta variant has kept Covid-19 top of mind for many investors. While it’s true that some pharmaceutical stocks were part of the vaccine race, other players in the space have not performed as well as was hoped. Case in point, as of October 6, 2021, the iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is up only 9.7% in the last 12 months. And if you bought shares of the fund at the beginning of the year, you have no growth to show for your patience.

There are reasons beyond Covid-19 to consider when assessing the disappointing performance of pharmaceutical stocks. One is the current political climate which is making no secret of its desire to reshape the healthcare industry. And it has the pricing practices of “big pharma” firmly in its crosshairs.

However, the pharmaceutical sector is still loaded with quality stocks for investors who are willing to accept the inherent risk. And that’s the focus of this special presentation. In the next few minutes, we’ll take a look at seven pharmaceutical stocks that are ready to make strong moves forward in 2022.

View the "7 Pharmaceutical Stocks to Buy For a Healthy Portfolio in 2022".


Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.